Consonance Capital Management LP Insmed Inc Transaction History
Consonance Capital Management LP
- $7.28 Million
- Q3 2022
Shares
2 transactions
Others Institutions Holding INSM
# of Institutions
468Shares Held
175MCall Options Held
5.26MPut Options Held
5.07M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.01 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$859 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$461 Million0.09% of portfolio
-
State Street Corp Boston, MA6.18MShares$436 Million0.02% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.56B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...